TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biokjemi Norge AS
Closing information (x1000 SEK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
23,222
|
20,028
|
25,575 |
| Financial expenses |
286
|
226
|
197 |
| Earnings before taxes |
350
|
-1,864
|
1,078 |
| Total assets |
12,969
|
13,389
|
11,973 |
| Current assets |
10,117
|
10,157
|
8,644 |
| Current liabilities |
7,766
|
8,192
|
5,124 |
| Equity capital |
5,203
|
5,197
|
6,849 |
| - share capital |
99
|
106
|
103 |
| Employees (average) |
6
|
6 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
40.1%
|
38.8%
|
57.2% |
| Turnover per employee |
3,338
|
4,262 | |
| Profit as a percentage of turnover |
1.5%
|
-9.3%
|
4.2% |
| Return on assets (ROA) |
4.9%
|
-12.2%
|
10.6% |
| Current ratio |
130.3%
|
124.0%
|
168.7% |
| Return on equity (ROE) |
6.7%
|
-35.9%
|
15.7% |
| Change turnover |
4,521
|
-6,339
|
-4,522 |
| Change turnover % |
24%
|
-24%
|
-15% |
| Chg. No. of employees |
0
|
0 | |
| Chg. No. of employees % |
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.